Elke Kuypers1, Monique G M Willems1, Reint K Jellema1, Matthew W Kemp2, John P Newnham2, Tammo Delhaas1, Suhas G Kallapur3, Alan H Jobe3, Tim G A M Wolfs1, Boris W Kramer4. 1. Department of Pediatrics, School of Mental Health and Neuroscience, School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. 2. School of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia. 3. 1] School of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia [2] Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio. 4. 1] Department of Pediatrics, School of Mental Health and Neuroscience, School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands [2] School of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia.
Abstract
BACKGROUND: Intrauterine inflammation activates the fetal immune system and can result in organ injury and postnatal complications in preterm infants. As the spleen is an important site for peripheral immune activation, we asked how the fetal spleen would respond to intrauterine inflammation over time. We hypothesized that intraamniotic lipopolysaccharide (IA LPS) exposure induces acute and persistent changes in the splenic cytokine profile and T-cell composition that may contribute to the sustained fetal inflammatory response after chorioamnionitis. METHODS: Fetal sheep were exposed to IA LPS 5, 12, and 24 h and 2, 4, 8, or 15 d before delivery at 125 d of gestational age (term = 150 d). Splenic cytokine mRNA levels and cleaved caspase-3, CD3, and Foxp3 expression were evaluated. RESULTS: IA LPS increased interleukin (IL)1, IL4, IL5, and IL10 mRNA by twofold 24 h after injection. Interferon gamma increased by fivefold, whereas IL23 decreased 15 d post-LPS exposure. Cleaved caspase-3-positive cells increased 2 and 8 d after LPS exposure. CD3 immunoreactivity increased within 5 h with increased Foxp3-positive cells at 12 h. CONCLUSION: Intrauterine inflammation induced a rapid and sustained splenic immune response with persistent changes in the cytokine profile. This altered immune status may drive sustained inflammation and injury in other fetal organs.
BACKGROUND:Intrauterine inflammation activates the fetal immune system and can result in organ injury and postnatal complications in preterm infants. As the spleen is an important site for peripheral immune activation, we asked how the fetal spleen would respond to intrauterine inflammation over time. We hypothesized that intraamniotic lipopolysaccharide (IA LPS) exposure induces acute and persistent changes in the splenic cytokine profile and T-cell composition that may contribute to the sustained fetal inflammatory response after chorioamnionitis. METHODS: Fetal sheep were exposed to IA LPS 5, 12, and 24 h and 2, 4, 8, or 15 d before delivery at 125 d of gestational age (term = 150 d). Splenic cytokine mRNA levels and cleaved caspase-3, CD3, and Foxp3 expression were evaluated. RESULTS: IA LPS increased interleukin (IL)1, IL4, IL5, and IL10 mRNA by twofold 24 h after injection. Interferon gamma increased by fivefold, whereas IL23 decreased 15 d post-LPS exposure. Cleaved caspase-3-positive cells increased 2 and 8 d after LPS exposure. CD3 immunoreactivity increased within 5 h with increased Foxp3-positive cells at 12 h. CONCLUSION:Intrauterine inflammation induced a rapid and sustained splenic immune response with persistent changes in the cytokine profile. This altered immune status may drive sustained inflammation and injury in other fetal organs.
Authors: Jodi K Regan; Paranthaman S Kannan; Matthew W Kemp; Boris W Kramer; John P Newnham; Alan H Jobe; Suhas G Kallapur Journal: Reprod Sci Date: 2015-07-07 Impact factor: 3.060
Authors: Cathelijne Heymans; Marcel den Dulk; Kaatje Lenaerts; Lara R Heij; Ilse H de Lange; Mhamed Hadfoune; Chantal van Heugten; Boris W Kramer; Alan H Jobe; Masatoshi Saito; Matthew W Kemp; Tim G A M Wolfs; Wim G van Gemert Journal: Sci Rep Date: 2021-05-14 Impact factor: 4.379
Authors: Martin Mueller; Tim G A Wolfs; Andreina Schoeberlein; Antonio W D Gavilanes; Daniel Surbek; Boris W Kramer Journal: Mol Cell Pediatr Date: 2016-02-11
Authors: Nicoletta Di Simone; Fiorella Di Nicuolo; Riccardo Marana; Roberta Castellani; Francesco Ria; Manuela Veglia; Giovanni Scambia; Daniel Surbek; Eytan Barnea; Martin Mueller Journal: PLoS One Date: 2017-07-12 Impact factor: 3.240
Authors: Anne Marie Singh; Michael G Sherenian; Kwang-Youn Kim; Kristin A Erickson; Amy Yang; Karen Mestan; Linda M Ernst; Rajesh Kumar Journal: Allergy Asthma Clin Immunol Date: 2018-11-19 Impact factor: 3.406
Authors: Megan Hall; Jana Hutter; Natalie Suff; Carla Avena Zampieri; Rachel M Tribe; Andrew Shennan; Mary Rutherford; Lisa Story Journal: Prenat Diagn Date: 2022-06-17 Impact factor: 3.242